CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terry, M. B.
Right arrow Articles by Fenoglio-Preiser, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terry, M. B.
Right arrow Articles by Fenoglio-Preiser, C. M.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 660-663, July 2002
© 2002 American Association for Cancer Research


Short Communications

Reliability in the Classification of Advanced Colorectal Adenomas

Mary Beth Terry1, Alfred I. Neugut, Roberd M. Bostick, John D. Potter, Robert W. Haile and Cecilia M. Fenoglio-Preiser

Department of Epidemiology, Joseph L. Mailman School of Public Health [M. B. T., A. I. N.], Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons [M. B. T., A. I. N.], and Department of Medicine, College of Physicians and Surgeons [A. I. N.], Columbia University, New York, New York 10032; South Carolina Cancer Center, University of South Carolina, Columbia, South Carolina 29203 [R. M. B.]; Cancer Prevention Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [J. D. P.]; Department of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California 90033 [R. W. H.]; and Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267-0529 [C. F-P.]

In conjunction with a pooled analysis of risk factors for advanced adenomas [adenomas with severe dysplasia, carcinoma in situ (CIS), and intramucosal carcinoma], we undertook a reliability study on the pathological diagnosis of advanced adenomas. We assessed intraobserver agreement (using Kappa ({kappa}) as the measure of agreement) across two time periods 10 years apart with a single pathologist and interobserver agreement (using Kappa) between two pathologists rating the same slides concurrently. The study pathologists were blinded to the original case classification. We used the slides of 190 colorectal adenomatous polyp cases (104 originally diagnosed as advanced adenomas, 86 adenomas without advanced lesions) from a colonoscopy-based case-control study conducted in New York City between 1986 and 1988. We also assessed conditional agreement for 71 slides of advanced adenomas from four adenoma case-control studies conducted in different geographic regions of the United States in the 1990s. Intra- and interobserver agreement was only fair to moderate on the classification of both histological type (villous, tubulovillous, and tubular: intraobserver {kappa} = 0.28; 95% confidence interval (CI), 0.17–0.39; interobserver {kappa} = 0.48; 95% CI, 0.33–0.62) and degree of dysplasia (none/mild, moderate, severe, CIS, and intramucosal: intraobserver {kappa} = 0.20; 95% CI, 0.12–0.28; interobserver {kappa} = 0.42; 95% CI, 0.29–0.55). Using broader, rather than finer, classifications for degree of dysplasia substantially improved the reliability (interobserver agreement for high-grade dysplasia (including severe dysplasia, CIS, and intramucosal carcinoma) versus low-grade dysplasia: {kappa} = 0.69; 95% CI, 0.55–0.83). These findings suggest that future epidemiological studies of advanced adenomas should use broad categories, such as high-grade versus low-grade dysplasia, include central review of all slides, and take measurement error into account in sample size calculations.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. B. Terry, A. I. Neugut, R. M. Bostick, R. S. Sandler, R. W. Haile, J. S. Jacobson, C. M. Fenoglio-Preiser, and J. D. Potter
Risk Factors for Advanced Colorectal Adenomas: A Pooled Analysis
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 622 - 629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.